Company intelligence / Profile preview

ImmunoBiology Limited

Babraham, Cambridgeshire, United Kingdomimmunobiology.arizona.edu ↗

Ownership: Private
Development stage: Phase 3

Overview

IMMUNOBIOLOGY LIMITED is an active UK-based private limited biotechnology company incorporated since 1999 that focuses on research and experimental development within biotechnology/immunology sectors. It does not appear to be a commercial-stage pharma/biotech firm with disclosed therapeutic modalities or clinical programs at present. There is no evidence it has been acquired or operates under other names.

Industry: Biotech

Drug pipeline

4 assets

hyperimmune caprine serum against hiv lysate

3 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on ImmunoBiology Limited.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ImmunoBiology Limited.

Explore the full profile